5 Questions is a new series of Blood, Sweat and Smears, hosted by our Senior Director, Bjorn Stromsness who asks 5 questions to physicians in and around the disease areas we work in. In this episode, we are joined by Dr. S...

In this episode of Blood, Sweat and Smears, our senior director of Business Development, Bjorn Stromsness, attended the American Society of Hematology (ASH) 2024 in San Diego, CA, and asked nephrologists 1 question: what is the most critica...

In this podcast, our Medical Director, Dr. Brad Lewis, talks with Dr. Robert Brodsky, a Professor of Medicine and Oncology and Director of Hematology at Johns Hopkins University School of Medicine in BaltimoreDr. Lewis and Dr. Brodsky d...

In this episode of Blood, Sweat and Smears, our senior director of Business Development, Bjorn Stromsness, attended the American Society of Nephrology (ASN) Kidney Week 2024 in San Diego, CA, and asked nephrologists 1 question: what is the ...

5 Questions is a new series of Blood, Sweat and Smears, hosted by our Senior Director, Bjorn Stromsness, who asks 5 questions to physicians in and around the disease areas we work in. In this episode, we are joined by Dr. Xiao Peng...

5 Questions is a new series of Blood, Sweat and Smears, hosted by our Senior Director, Bjorn Stromsness, who asks 5 questions to physicians in and around the disease areas we work in. In this episode, we are joined by Dr. Anita Dha...

5 Questions is a new series of Blood, Sweat and Smears, hosted by our Senior Director, Bjorn Stromsness who asks 5 questions to physicians in and around the disease areas we work in. In this episode, we are joined by Dr. A...

5 Questions is a new series of Blood, Sweat and Smears, hosted by our Senior Director, Bjorn Stromsness who asks 5 questions to physicians in and around the disease areas we work in. In this episode, we are joined by Dr. P...

In this podcast our Medical Director, Dr. Brad Lewis, discusses mixing studies- more specifically what a mixing study is and what it isn't, as well as a few quirks we see in some of the mixing studies. Click here ➡️

In this podcast, our Medical Director, Dr. Brad Lewis, discusses heparin-induced thrombocytopenia, also known as HIT. Dr. Lewis addresses what HIT is, how to diagnose and interpret testing, and the role of functional testing like t...

In this podcast, our Medical Director, Dr. Brad Lewis, talks with Dr. Scott Canna, from the Division of Rheumatology and the Immune Dysregulation Program at Children's Hospital of Philadelphia. Dr. Lewis and Dr. Canna discuss Hemophagoc...

In this podcast, our Medical Director, Brad Lewis, discusses a  pediatric case of aHUS with Dr. Amara Finch, a Pediatric Resident Physician at the University of Utah.Dr. Finch presents a fascinating case of atypical hemolytic uremi...

In this podcast, our Medical Director, Brad Lewis, talks with Dr. Christina Klein, a transplant nephrologist and the head of the transplant program at Piedmont Transplant Institute in Atlanta, GA. Dr. Lewis and Dr. Klein discuss re...

In this podcast, our Medical Director, Brad Lewis, continues his conversation with Jamey Kain, Vice President of Genetic Innovation here at Machaon. Brad and Jamey discuss what next-generation sequencing (NGS) is, why it's importan...

In this podcast, our Medical Director, Brad Lewis, talks with Jamey Kain, Vice President of Genetic Innovation here at Machaon. Brad and Jamey discuss how we design our genetic panels, what goes in, what stays out and how we think about clinica...

Join Dr. Kerstin de Wit and our Medical Director, Dr. Brad Lewis, discuss the importance of accessing and educating patients with newly diagnosed venous thrombotic disease. Many patient factors, including age, sex, activity and knowledge levels...

In this episode we hear an interview with Mike Ero, Machaon Diagnostics' Founder and CEO. A Clinical Laboratory Scientist (CLS) who added an MBA, Mike started Machaon Diagnostics back in 2003 at the age of 29. Just how did all of that come abou...

Andra James, MD, MPH is a Professor of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine at Duke University Center, and consulting professor of Medicine, Division of Hematology. She is also the founder of Duke University's Women'...

Our Medical Director, Brad Lewis, MD, discusses COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) and diagnostic strategies. 

In this episode Dr. Brad Lewis talks about PAI-1, testing for PAI-1 and where things look to be heading for the future of this gene and conditions associated with it.We released this episode to coincide with Pi Day (3.14).

Join Michelle Hermiston, MD, PhD - Associate Professor of Pediatrics (Pediatric Hematologist/Oncologist) at UCSF and our Medical Director, Brad Lewis, MD, discuss the challenges of diagnosing Hemophagocytic Lymphohistiocytosis or HLH, possible ...

Our Medical Director, Brad Lewis, MD, discusses aHUS/TMAs in pregnancy with Richard Burwick, MD, MPH - Assistant Professor, Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Cedars-Sinai Medical Center.If you...

Our Medical Director, Brad Lewis, addresses a number of questions around hypercoagulability and COVID-19.

Dr. Brad Lewis discusses sC5b-9 in this podcast addressing; what sC5b-9 testing is, why you want to know about this test and when to use it. Dr. Lewis also explores how it helps when trying to confirm a diagnosis. 

Dr. Brad Lewis discusses hemophagocytic lymphohistiocytosis (HLH); when you want to think about HLH, why you want to think about HLH, and how to diagnose this disorder.